The serum IL-12:IL-6 ratio reliably distinguishes infectious from non-infectious causes of fever during autologous stem cell transplantation

References

• Salazar R, Sola C, Maroto P, et al. Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999; 23: 27–33
   PubMed Web of Science ®Google Scholar
• Kolbe K, Domkin D, Derigs HG, et al. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 143–7
   PubMed Web of Science ®Google Scholar
• Reich G, Mapara MY, Reichardt P, et al. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 2001; 27: 525–9
   PubMed Web of Science ®Google Scholar
• Hughes, WT, Armstrong, D, Bodey, GP, , et al, 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730–51.
   PubMed Web of Science ®Google Scholar
• Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893–8
   PubMed Web of Science ®Google Scholar
• Groeneveld AB, Bossink AW, van Mierlo GJ, Hack CE. Circulating inflammatory mediators in patients with fever: predicting bloodstream infection. Clin Diagn Lab Immunol 2001; 8: 1189–95
   PubMedGoogle Scholar
• Aalto H, Takala A, Kautiainen H, Repo H. Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. Eur J Clin Microbiol Infect Dis 2004; 23: 699–704
   PubMed Web of Science ®Google Scholar
• Kallio R, Surcel HM, Bloigu A, Syrjala H. Balance between interleukin-10 and interleukin-12 in adult cancer patients with or without infections. Eur J Cancer 2001; 37: 857–61
   PubMed Web of Science ®Google Scholar
• Svaldi M, Hirber J, Lanthaler AI, et al. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 2001; 115: 53–7
   PubMed Web of Science ®Google Scholar
• Guven H, Altintop L, Baydin A, et al. Diagnostic value of procalcitonin levels as an early indicator of sepsis. Am J Emerg Med 2002; 20: 202–6
   PubMed Web of Science ®Google Scholar
• Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396–402
   PubMed Web of Science ®Google Scholar
• Persson L, Engervall P, Magnuson A, et al. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 2004; 36: 365–71
   PubMed Web of Science ®Google Scholar
• de Bont ES, Vellenga E, Swaanenburg JC, et al. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br J Haematol 1999; 107: 375–80
   PubMed Web of Science ®Google Scholar
• Ruokonen E, Nousiainen T, Pulkki K, Takala J. Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis 1999; 18: 283–5
   PubMed Web of Science ®Google Scholar
• Heney D, Lewis IJ, Evans SW, et al. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis 1992; 165: 886–90
   PubMed Web of Science ®Google Scholar
• Lehrnbecher T, Venzon D, de Haas M, et al. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis 1999; 29: 414–19
   PubMed Web of Science ®Google Scholar
• Engel A, Mack E, Kern P, Kern WV. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 1998; 26: 213–21
   PubMed Web of Science ®Google Scholar
• Stryjewski GR, Nylen ES, Bell MJ, et al. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med 2005; 6: 129–35
   PubMedGoogle Scholar
• Bernard L, Ferriere F, Casassus P, et al. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 1998; 27: 914–15
   PubMed Web of Science ®Google Scholar
• Engel A, Steinbach G, Kern P, Kern WV. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 1999; 31: 185–9
   PubMed Web of Science ®Google Scholar
• Riikonen P, Saarinen UM, Teppo AM, et al. Cytokine and acute-phase reactant levels in serum of children with cancer admitted for fever and neutropenia. J Infect Dis 1992; 166: 432–6
   PubMed Web of Science ®Google Scholar
• Ortega M, Rovira M, Almela M, et al. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation. Bone Marrow Transplant 2004; 33: 741–4
   PubMed Web of Science ®Google Scholar
• von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 2004; 23: 539–44
   PubMed Web of Science ®Google Scholar
• Blijlevens NM, Donnelly JP, Meis JF, et al. Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation. Clin Diagn Lab Immunol 2000; 7: 889–92
   PubMedGoogle Scholar
• Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978; 8: 283–98
   PubMed Web of Science ®Google Scholar
• Netea MG, Kullberg BJ, Van der Meer JW. Circulating cytokines as mediators of fever. Clin Infect Dis 2000; 31(Suppl 5)S178–84
   PubMed Web of Science ®Google Scholar
• Watford WT, Moriguchi M, Morinobu A, O'Shea JJ. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 2003; 14: 361–8
   PubMed Web of Science ®Google Scholar
• Langrish CL, McKenzie BS, Wilson NJ, et al. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 2004; 202: 96–105
   PubMed Web of Science ®Google Scholar
• Emmanuilidis K, Weighardt H, Matevossian E, et al. Differential regulation of systemic IL-18 and IL-12 release during postoperative sepsis: high serum IL-18 as an early predictive indicator of lethal outcome. Shock 2002; 18: 301–5
   PubMed Web of Science ®Google Scholar
• Nijhuis CO, Kamps WA, Daenen SMG, et al. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol 2005; 23: 7437–44
   PubMed Web of Science ®Google Scholar